Modulight

Kurs

+0,13%

Likviditet

0,04 MEUR

Prenumeration

Kalender

	Est. tid*
2026-10-23	12:00	Kvartalsrapport 2026-Q3
2026-08-21	12:00	Kvartalsrapport 2026-Q2
2026-05-04	N/A	Årsstämma
2026-04-24	12:00	Kvartalsrapport 2026-Q1
2026-02-20	12:00	Bokslutskommuniké 2025
2025-10-24	-	Kvartalsrapport 2025-Q3
2025-08-22	-	Kvartalsrapport 2025-Q2
2025-05-05	-	X-dag ordinarie utdelning MODU 0.00 EUR
2025-05-02	-	Årsstämma
2025-04-25	-	Kvartalsrapport 2025-Q1
2025-02-21	-	Bokslutskommuniké 2024
2024-10-18	-	Kvartalsrapport 2024-Q3
2024-08-16	-	Kvartalsrapport 2024-Q2
2024-05-06	-	X-dag ordinarie utdelning MODU 0.00 EUR
2024-04-26	-	Kvartalsrapport 2024-Q1
2024-02-23	-	Bokslutskommuniké 2023
2023-10-20	-	15-10 2023-Q3
2023-08-18	-	Kvartalsrapport 2023-Q2
2023-05-03	-	X-dag ordinarie utdelning MODU 0.00 EUR
2023-05-02	-	Årsstämma
2023-04-28	-	15-10 2023-Q1
2023-02-23	-	Bokslutskommuniké 2022
2022-08-19	-	Kvartalsrapport 2022-Q2
2022-05-03	-	X-dag ordinarie utdelning MODU 0.00 EUR
2022-05-02	-	Årsstämma

Beskrivning

Land	Finland
Lista	First North Finland
Sektor	Hälsovård
Industri	Medicinteknik

Modulight är verksamt inom teknikbranschen. Bolaget designar, marknadsför och producerar biomedicinska laserprodukter som används inom onkologi, genetik och oftalmologi. Kunderna består huvudsakligen av sjukhus och företagskunder verksamma inom medicinteknik. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster. Störst verksamhet återfinns inom Europa.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

Modulight to publish its business review for January–September 2023 on October 20, 2023

2023-10-13 08:55:00

Modulight Corporation | Press Release | October 13, 2023 at 09:55:00 EEST

Modulight Corporation will publish its business review for January–September 2023 on Friday, October 20, 2023, at 1:00 p.m. EEST.

Modulight's CEO Seppo Orsila will present the result in an English-language webcast, which will be held on October 20, 2023, at 2:30 p.m. EEST. The broadcast can be followed at modulight.videosync.fi/q3-2023-results. Questions are to be submitted in writing in the webcast portal. CFO Anca Guina will also be present to answer questions. Presentation materials will be available before the start of the event on the company’s website at modulight.com/reports-presentations/.

Modulight in brief

Modulight Corporation is a biomedical laser company that designs and manufactures products for oncology, ophthalmology and genetics. The company also provides solutions for selected high value-add applications including quantum computing and digital press. The company’s products include medical devices, subsystems, software, cloud services and specialized semiconductors. Modulight’s products are used worldwide by many Fortune 500 companies, pharmaceutical companies, and well-known cancer centers and universities. Modulight was founded in 2000 and is headquartered in Tampere, Finland.

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Modulight

Kurs +0,13%

Likviditet 0,04 MEUR